BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 120222
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120222
Table 1 Baseline demographic and clinical characteristics of patients before and after propensity score matching, n (%)/mean ± SD
CharacteristicPre-matched cohort
Post-matched cohort (n = 125 pairs)
Watson-FTS (n = 165)
Routine care (n = 147)
Test statistic
P value
SMD
Watson-FTS (n = 125)
Routine care (n = 125)
Test statistic
P value
SMD
Demographics
Age, years62.1 ± 10.864.5 ± 11.41.910.0570.2263.2 ± 10.563.5 ± 10.90.220.8250.03
Male gender96 (58.2)85 (57.8)0.010.9480.0172 (57.6)71 (56.8)0.020.8980.02
BMI, kg/m223.6 ± 3.423.1 ± 3.71.240.2160.1423.4 ± 3.223.3 ± 3.50.240.8140.03
Education (> high school)91 (55.2)59 (40.1)6.990.0080.3158 (46.4)60 (48.0)0.060.7990.03
Clinical status
ASA class III45 (27.3)38 (25.9)0.080.7760.0334 (27.2)33 (26.4)0.020.8870.02
NRS 2002 score2.6 ± 0.92.5 ± 1.10.880.380.12.5 ± 0.82.5 ± 0.9010
CCI score2.4 ± 1.52.6 ± 1.71.10.2720.122.5 ± 1.42.5 ± 1.5010
Smoking (current/former)64 (38.8)61 (41.5)0.240.6240.0649 (39.2)51 (40.8)0.070.7960.03
Neoadjuvant therapy35 (21.2)28 (19.0)0.240.6270.0525 (20.0)26 (20.8)0.020.8790.02
Psychological status
HADS-anxiety9.6 ± 3.17.9 ± 3.44.61< 0.0010.528.8 ± 2.98.9 ± 3.20.260.7950.03
HADS-depression8.9 ± 3.37.4 ± 3.24.07< 0.0010.468.2 ± 3.08.3 ± 2.80.270.7850.03
Surgical/oncological
Laparoscopic approach140 (84.8)101 (68.7)11.520.0010.495 (76.0)94 (75.2)0.020.8850.02
AJCC TNM stage III88 (53.3)76 (51.7)0.080.7750.0366 (52.8)65 (52.0)0.020.8980.02
Tumor location (rectum)102 (61.8)94 (63.9)0.150.6970.0478 (62.4)79 (63.2)0.020.8940.02
Permanent stoma65 (39.4)62 (42.2)0.250.6170.0650 (40.0)49 (39.2)0.020.8920.02
Preop albumin, g/L36.4 ± 4.536.9 ± 4.80.950.3430.1136.6 ± 4.236.7 ± 4.40.180.8540.02
Preop prealbumin, mg/L224 ± 51219 ± 550.830.4070.09221 ± 48223 ± 500.320.7480.04


Write to the Help Desk